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Abstract
Background: Asthma is a worldwide health burden with an alarming prevalence. For years, asthma-associated
airway injury remains elusive. Transforming growth factor β1 (TGF-β1) is a pleiotropic cytokine that has been shown
to be involved in the synthesis of the matrix molecules associated with airway remodeling. Human antigen R (HuR),
the member of the Hu RNA-binding protein family, can bind to a subset of short-lived mRNAs in their 3′
untranslated regions (UTR). However, the functional roles and relevant signaling pathways of HuR in airway
remodeling have not been well illustrated. Thus, we aim to explore the relationship between HuR and TGF-β1 in
platelet derived growth factor(PDGF)-induced airway smooth muscle (ASM) cells and asthmatic animal.
Methods: Cultured human ASM cells were stimulated by PDGF for 0, 6, 12 and 24 h. Western blotting, RT-PCR and
immunofluoresence were used to detect the expression of HuR, TGF-β1, α-smooth muscle actins (α-SMA) and
collagen type I (Col-I). Then knockdown of HuR, flow cytomerty was used to detect the morphological change and
western blotting for functionally change of ASM cells. Furthermore, the interference of TGF-β1 and exogenous TGF-
β1 were implemented to testify the influence on HuR. A murine OVA-driven allergic model based on sensitization
and challenge was developed. The inflammatory response was measured by bronchoalveolar lavage fluid (BALF),
airway damage was analyzed by hematoxylin and eosin staining, airway remodeling was assessed by sirius red
staining and periodic acid-schiff staining, the expression level of HuR, TGF-β1 and α-SMA were measured by RT-PCR,
western blotting and immunohistochemistry.
Results: Here, we found that PDGF elevated HuR expression both at mRNA and protein level in cultured ASM cells
at a time-dependent manner, which was simultaneously accompanied by the enhanced expression of TGF-β1, α-
SMA and Col-I. Further study revealed that the knockdown of HuR significantly increased the apoptosis of ASM cells
and dampened TGF-β1, Col-I and α-SMA expression. However, interfering TGF-β1 with siRNA or extra addition of
TGF-β1, HuR could restore its production as well as Col-I. Compared with normal mice stimulating with PBS, OVA-
induced mice owned high amount of inflammatory cells, such as eosinophils, lymphocytes and neutrophils except
macrophages. HE staining showed accumulation of inflammatory cells surrounding bronchiole and sirius red
staining distinguished collagen type I and III deposition around the bronchiole. Higher abundance of HuR, TGF-β1
and α-SMA were verified in OVA-induced mice than PBS-induced mice by RT-PCR, western blotting and
immunohistochemistry.
Conclusions: A HuR/TGF-β1 feedback circuit was established to regulate airway remodeling in vivo and in vitro
and targeting this feedback has considerable potential for the intervention of asthma.
Keywords: Asthma, Human antigen R, Transforming growth factor, α-smooth muscle actins, Collagen 1a, Airway
remodeling, Post-transcription regulation
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Background
Airway remodeling, a fundamental pathogenic feature of
asthma, is characterized by matrix deposition and en-
hanced smooth muscle mass in the airways. For patients
with recurring episodes of asthma, structural changes
are one of the most important reasons for the deterior-
ation of lung function, which is now becoming a life-
threatening challenge in the treatment of asthma [1, 2].
Grainge [3] had confirmed that collagen deposition and
goblet cell hyperplasia contributed to airway remodeling
in mild asthma, but detailed mechanism remained to be
elucidated.
TGF-β1, a pleiotropic cytokine that had been evidenced
to be involved in the synthesis of matrix molecules in the
ASM cells, especially on the synthesis of collagen types I,
III, IV, VII and X, fibronectin and proteoglycans [4], has
been implicated in the pathogenesis of airway remodeling
in asthma [5–7]. For years, the mechanisms underlying
the development of fibrosis have been extensively studied
and multiple signal pathways are involved in, such as the
integrin α5β6 [8], phosphatidylcholine-specific phospho-
lipase C, protein kinase C-delta [9], the integrin receptor
α5β1 [10], the canonical Smad-dependent signaling
pathway [11] and p38 MAPK [12]. In recent years, a
series of observations reported that Angiotensin II
could be a putative mediator in increasing TGF-β1 and
Col-I deposition [13–15]. Although the roles of these
signaling pathways have been well established by ample
experimental studies, no specific inhibitor applicable in
asthma has been described.
HuR, the sole ubiquitous member of the Hu RNA-
binding protein family, can bind to a subset of short-
lived mRNAs that harbor AU-rich elements (AREs) in
their 3′ untranslated regions (UTR), which is called
post-transcriptional gene regulation that coordinating
the process of mRNA splicing, transport, turnover, and
translation in multiple development processes and dis-
eases [16]. These mRNAs include c-fos, VEGF, TNF, α,β-
catenin, c-myc, cyclooxygenase 2, myogenin, MyoD, and
granulocyte/macrophage colony-stimulating factor (GM-
CSF) [17–19]. Fan [20] has showed that HuR critically
regulates the epithelial response by associating with mul-
tiple functionally related ARE-bearing inflammatory
transcripts, and Zhang [21] also reported that HuR par-
ticipated in ASM proliferation by mediating CyclinD1
expression. In particular, TGF-β1 3′UTR was reported
to be a putative target of HuR in human cancer cells
[22]. However, the underlying relationship between HuR
and TGF-β1 in regarding to airway remodeling has been
reported in few studies. So it is still a challenge to ex-
plore the possible pathogenic mechanisms of refractory
airway remodeling.
In our study, we found a novel HuR/TGF-β1 feedback
circuit that modulating airway remodeling in airway
smooth muscle cells and in asthmatic mouse firstly. In
vitro, we detected that HuR and TGF-β1 demonstrated
high expression in a time-dependent manner under the
stimulation of PDGF, a strong stimulus for asthmatic re-
sponse. Besides, α-SMA and Col-I simultaneously exhib-
ited over-expression. Furthermore, knockdown of HuR led
to an increase of ASM cells apoptosis and down-regulation
of TGF-β1, α-SMA and Col-I. Moreover, the half-life of
TGF-β1 was shorter compared with the control. However,
interfering TGF-β1 with siRNA can obviously decrease
HuR and Col-I expression. But exogenous TGF-β1 could
recover HuR and Col-I expression. In vivo, OVA-induced
mice showed widely infiltration of inflammatory cells sur-
rounding the bronchioles in comparison with PBS-induced
mice. Sirius red staining distinguished higher deposition of
collagen type I and III around the bronchiole in OVA-
induced mice then in PBS-induced mice. RT-PCR, western
blotting and immunohistochemistry all showed higher
levels of HuR, TGF-β1 and α-SMA in OVA -induced mice
than PBS-induced mice. Thus we hypothesized that a
HuR/TGF-β1 feedback is involved in airway remodeling
and targeting them might have considerable potential
for the control of asthma.
Methods
Cell culture and animals
Human bronchial smooth muscle (ASM) cells were pur-
chased from Cambrex Bio Science (Walkersville, MD).
Cells were cultured in DMEM cell medium (Hyclone)
containing 10 % fetal bovine serum supplemented with
100 U/ml penicillin and 100 μg/ml streptomycin. Cells
at passages between 4 and 11 were used for all experi-
ments, because later passage cells showed greater inter-
culture variability. For PDGF treatment, cells were
plated and cultured in complete DMEM overnight. Next
day, cells were divided into different groups according to
the different compounds added. For control group, no
compounds were administrated. For PDGF group, cells
were stimulated with 20 ng/ml PDGF and cultured for 0,
6, 12 and 24 h.
A total of 30 BALB/c female mice (age, 8–10 weeks;
weight, 22 ± 2 g) were purchased from the Laboratory
Animal Center of Shandong University and were housed
under specific pathogen-free conditions. All mice had ac-
cess to food and water free. Briefly, a model consists of
three intraperitoneal sensitization on days 0, 7 and 14,
followed by seven consecutive challenges with 5 % ovalbu-
min grade III (Sigma-Aldrich) aerosols for 30 min each
day. For sensitization, OVA grade V was dissolved to a
final concentration of 20 μg/ml in 500 μl sterile PBS per
mouse. Add alum to a concentration of 2 mg/ml. The
negative control mice received the same volume of
phosphate-buffered saline (PBS) by intraperitoneal injec-
tion for three times, then undergo airway challenge. No
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exogenous adjuvants were given at any time [23]. More de-
tailed protocol was listed in Fig 1. All experimental proce-
dures of the mice were performed in compliance with the
guidelines of the Institutional Animal Care and Use Com-
mittee. The protocol was approved by the Committee
on the Ethics of Animal Experiments of Shandong
Provincial Hospital affiliated to Shandong University.
Materials
Anti-HuR (ab17397, Abcam), TGF-β1 (ab92486,Abcam),
α-SMA (ab5694, Abcam), collagen I (ab34710, Abam),
and actin (ab8226, Abcam) antibodies were available for
western blotting, immunohistochemistry and immuno-
fluoresence. Reverse kit was purchased from Takara
(Japan). PDGF-BB was purchased from Peprotech and
recombinant human TGF-β1 was bought from Invitrogen.
Small interference RNA duplexes against HuR and TGF-
β1 plus negative control were synthesized in Genepharm
(Shanghai, China). Lip3000 and Trizol was purchased
from Invitrogen. TGF-β1 and human Col-I ELISA kit
were bought from Bioworld. All other reagents were en-
rolled from domestic companies with good reputations
unless specifically stated.
Real-time PCR
Cells were harvested and total RNA was isolated with
Trizol. In mice, the total RNA was extracted from the
right lungs using Trizol (Invitrogen, USA). Reverse tran-
scription of 1 μg RNA was carried out according to the
instructions of Takara RT kit (Japan). Quantitect SYBR
Green kit (USA) was used for amplification and fluores-
cence was detected by using ABI Prism 7700 Detection
System. GAPDH was run as internal control and 2−ΔΔCt
method was performed for analysis (n = 3). To test the
TGF-β1 mRNA stability, ASM cells transfected with
ConsiRNA or HuRsiRNA were further treated with
PDGF or without for 6 h. Then actinomycinD (5 μg/ml)
was added in every well immediately for 0, 4, 8 and 12 h
and RNA was extracted at indicated time to examine the
RNA abundance for stability analysis. Primers sequences
were listed at Table 1.
Western blotting
Harvested cells were rinased with PBS and lysed by
RIPA containing 50 mM Tris, 150 mM NaCl, 1 % Triton
X-100, 1 % Sodium deoxycholate, 0.1 % SDS plus protease
inhibitor PMSF. Lung tissues were homogenized with ice-
cold RIPA plus PMSF. Protein concentration was tested
by the BCA protein assay kit. Protein samples (30 μg per
lane) were submitted to electrophoresis on 10 % SDS-
polyacrylamide gel and resolved to PVDF membrane.
After blocking for 1 h (5 % non-fat milk in Tris buffered
saline plus 0.1 % Tween 20), the membranes were incu-
bated in blocking buffer at 4 °C overnight with anti-HuR
Fig. 1 Experimental protocols for chronic OVA-induced asthma in mice. BALB/c mice received three intraperitoneal sensitizations with ovalbmin
grade V mixed with the adjuvant aluminium hydroxide for emulsified on days 0, 7 and 14, followed by seven consecutive challenge each day
with 5 % ovalbumin grade III aerosols for 30 min. The negative control mice were received the same volume of phosphate-buffered saline (PBS)
by intraperitoneal injection for three times, then undergo airway challenge. No exogenous adjuvant was given at any time. The mice were sacrificed
with an over dose anaesthetized, BALF was performed, and the lungs were dissected for histological analysis
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(1:2000), anti-TGF-β1 (1:1000), anti-α-SMA (1:150) and
anti-Col I (1:1000). After three times washing next day,
the membranes were probed with HRP (1:5000 in block-
ing buffer) linked secondary antibodies, and visualized
with ECL reagent (Thermo Scientific).
Immunofluorescence
After the ASM cells were stimulated with PDGF for 0, 6,
12 and 24 h respectively, cells were fixed in 4 % parafor-
maldehyde for 15 min and permeabilized for 20 min in
phosphate-buffered saline containing 0.5 % Triton X-
100. After incubation in blocking buffer (goat serum) for
1 h at 37 °C, cover slips were incubated in a 1:50 dilu-
tion of anti-TGF-β1 and anti-HuR prepared in blocking
buffer overnight. Cover slips were washed with blocking
buffer next day and incubated for at least 1 h with
TRITC-labeled goats anti-rabbit IgG or anti-mouse IgG.
Then cover slips were washed for thee times with
blocking buffer and cells were dyed nucleus with DAPI
for 15 min. After carefully washing, cell images were
acquired with a fluorescence inverted microscope
(Olympus BX50).
RNA-interference
According to the manufacturer’s instructions, the
trypsinized ASM cells were resuspended at a density
of (0.25-1) × 106/ml in 6-well plate. 5 μl Lip3000 was
diluted in 125 μl OPTI-MEM and 2.5 μg DNA plus
5 μl P3000 were diluted in 125 μl OPTI-MEM. Then
two compounds were well mixed and incubated 10 min at
room temperature to form transfected complexes.
Then total 250 μl complexes were dispensed into a
culture plate containing 1750 μl complete DMEM
medium and mixed with the cell suspension gently.
Additional experiments were performed after transfec-
tion for 48 h.
Flow cytometry and CCK8 assay
Apoptosis assay: ASM cells were divided into Consi,
Consi + PDGF, HuRsi and HuRsi + PDGF groups. ASM
cells were then harvested, washed and resuspended with
PBS. Apoptotic cells were determined with an Alexa
Fluor 488 Annexin V/Dead Cell Apoptosis kit (Invitrogen)
according to the manufacturer’s protocol. Briefly, the cells
were washed and subsequently incubated in 100 μl of
1X Annexin binding buffer containing 5 μl of Annexin
V-FITC and 2 μl of propidium iodide (PI) for 15 min in
the dark. Then, apoptosis was analyzed using a FACS-
can laser flow cytometer. Data were analyzed by using
FlowJo software.
Cell proliferation assay: ASM cells were divided into
Consi, Consi + PDGF, TGFsi, TGFsi + PDGF groups.
10 μl CCK8 was added to each well. Cells were further
cultured for 1 h, and then when each well turned to or-
ange, the optical density(OD) was measured at 450 nm
using a multiscan reader. The average OD of four wells
for each group was calculated.
ELISA
The concentration of TGF-β1 and Col-I in the cultured
serum was measured by ELISA-kits. The protocols were
followed according to the manufacturer’s instructions.
Briefly, the cultured serum samples collecting from the
Consi and HuRsi group after cultured for indicated time
were added in triplicate to 96-well plates with 100 μl per
well. The appropriate biotinconjugated antibodies were
added to each well. The samples were incubated at room
temperature for 2 h. The wells were then aspirated, and
each well was washed five times. The substrate solutions
were added to each well, and were incubated for 30 min
at room temperature in the dark. The optical density
(OD) of each well was determined using a microplate
reader that was set to 450 nm. A standard curve was
created of the average of the OD duplicate readings.
Data was analyzed by CurveExpert 1.3 and SPSS 19.0.
Bronchoalveolar lavage fluid (BALF) and cell collection
All mice were sacrificed within 24 h after the last treat-
ment. The left major bronchus was tied with a string,
which was inserted with a 24-gauge needle, and the
BALF was obtained by the infusion and collection of
0.5 ml of saline. The infusion and collection steps were
repeated for 3 times. The BALF was centrifuged at
2000 rpm for 10 min at 4 °C.The different cell counts in
the BALF were carried out as described [24]. In brief,
the pellet was resuspended with 0.5 ml of saline and the
different cell counts were performed with Giemsa stain-
ing. The different cell counts were determined by light
microscopy from a count of at least 400 cells. The per-
centages of macrophages, eosinophils, lymphocytes and
neutrophils were determined by counting their numbers
Table 1 Primers and sequences used in this study
Name Sequence
GAPDH real time primer F-5′-GCAAGTTCAACGGCACAG-3′
R-5′-GCCAGTAGACTCCACGACATA-3′
HuR real time primer F-5′-GGCGAGCATACGACA3′
R-5′-TATTCGGGATAAAGTAGC3′
TGF-β1 real time primer F-5′-CCCACTGATACGCCTGAG-3′
R-5′-TGAAGCGAAAGCCCTGTA-3′
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in randomly selected high-power fields and by dividing
this number by the total number of cells per high-power
field. All of the counts were performed by the same ob-
server in a blinded manner and in a randomized order
at the end of the study.
Histology
The lungs were dissected from the chest cavity after the
lavage. The left lungs were immediately fixed in 4 %
paraformaldehyde and paraffin-embedded, and tissue
sections (5 mm) were prepared. To assess airway remod-
eling, the sections were stained with periodic acid Schiff
stain (PAS) for goblet cells and with Sirius red staining
for collagen deposition, as described previously [25].
Briefly, goblet cell upregulation within the airway epithe-
lia was assessed by measuring the length of the airway
basement membrane that was covered by goblet cells.
Peribronchial collagen thickness was measured using
Image-Pro Plus software (version 6, Media Cybernetics,
USA). Three bronchioles were selected at randomly
from each section and the mean depth of collagen in the
basement membrane was determined from five measure-
ments around the bronchiole. For immunohistochemical
analysis, the sections were initially incubated with anti-α-
SMA rabbit monoclonal antibody (1:150; Abcam), anti-
HuR rabbit monoclonal antibody (1:500; Abcam) and anti-
TGF-β1 rabbit polyclonal antibody (1:100; Abcam) at 4 °C
overnight, then were incubated with HRP-conjugated goat
anti-rabbit (1:50; Abcam) for 30 min at 37 °C. Positive
staining was detected with HRP-conjugated streptavidin,
visualized with 3,3′-diaminobenzidine and counterstained
with hematoxylin [26]. Finally, the sections were mounted,
cover-slipped, and examined under a light microscope
(Olympus BX50). The extent of positive area were analyzed
by using Image-Pro Plus 4.5.
Statistical analysis
All results were performed at least three independent
experiments. All data were processed by SPSS version
19.0 and quantitative data were shown as mean ± stand-
ard deviation (SD). A student’s t test (two-tailed) was
used to compare two groups and One-way ANOVA for
multiple comparisons. Quantity one V4.62 and Graph-
pad Prism 5.0 were used to quantify relative expression
of proteins. Values of P < 0.05 were considered statisti-
cally significant.
Results
PDGF treatment promoted TGF-β1 along with Col-I and
α-SMA expression
In our present study, we found that HuR expression ele-
vated in a time-dependent manner under the stimulation
of PDGF in cultured ASM cells, which was consistent
with the previous study (Fig 1a&b). To investigate whether
PDGF treatment could also affect the expression of TGF-
β1 plus Col-I and α-SMA, cultured ASM cells were
treated with 20 ng/ml PDGF for 0, 6, 12 and 24 h. TGF-β1
expression was detected at both the mRNA and protein
levels using real-time PCR and western blotting, respect-
ively. Compared with control (without PDGF treatment),
PDGF treatment for 6, 12 and 24 h elevated TGF-β1
mRNA levels by 27, 60 and 87 % separately(P < 0.05)
(Fig. 2a). Similar alterations could also be shown at TGF-
β1 protein levels, evidenced by 31, 69 and 106 % elevation
(P < 0.05) (Fig. 2b). Likewise, Col-I and α-SMA, a marker
of smooth muscle cells, were also increased in a time-
dependent manner (both P < 0.05) (Fig 2c&d). The relative
contents of all above three proteins were demonstrated in
Table 2. The subcellular distributions of HuR and TGF-β1
showed that PDGF stimulation for 6 h, especially in 12 h,
induced a significant elevation of total nuclear or cytoplas-
mic HuR and TGF-β1 abundance (Fig 2e). Collectively,
these results above provided direct evidence that PDGF
treatment promoted TGF-β1 along with Col-I and α-SMA
expression.
HuR silencing increased the apoptosis of ASM cells
Annexin V was used to detect the effects of HuR silen-
cing on the morphological change of ASM cells. As
shown in Fig 3a, there were no differences between the
Consi and HuRsi group at the beginning. However, we
could see the proportion of apoptosis in the Consi group
after cultured for 12 h were 1.236 %, while in the HuRsi
group was 3.315 % (P < 0.05). Western blotting was bet-
ter to evaluate the functional change after knockdown.
As seen from Fig 3b, the relative expression of HuR
protein in the HuRsi group was reduced 44.1 % com-
pared with the Consi group. mRNA levels showed
that a 28.8 % difference between the Consi and HuRsi
groupwas found. The results above showed that HuR
could protect ASM cells from apoptosis to a certain
extent.
HuR silencing decreased TGF-β1 expression via decreasing
the mRNA stability
We employed small interference RNA to determine
whether suppressing HuR expression could decrease
the PDGF-induced TGF-β1 expression in ASM cells.
Western blotting analysis demonstrated that HuR silen-
cing decreased HuR expression to very low level, simul-
taneously the TGF-β1 protein content was also decreased
in the HuR-silenced group (HuRsi) compared with the
silencing control groups (Consi) in a time-dependent
manner (Fig 4a). The concentration of TGF-β1 in the
cultured serum also showed the same alteration that
TGF-β1 obviously elevated in the Consi group espe-
cially in 12 h compared with the HuRsi group (Fig 4b)
(Table 3).
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Fig. 2 (See legend on next page.)
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On the basis of the observations that PDGF treatment
enhanced the TGF-β1 protein level and the expression
of TGF-β1 was decreased after the knockdown of HuR.
We further investigated whether mRNA stability change
occurred in the transfected ASM cells. The ASM cells
were left untreated or stimulated with PDGF for 6 h,
then either harvested or cultured in the presence of the
transcriptional inhibitor actinomycinD (5 μg/ml) for an
additional 4 h, 8 h and 12 h. As shown in Fig 4c, treat-
ment with actinomycinD revealed that there was a tiny
but consistent decrease in TGF-β1 mRNA half-life
(the time expressed in hours at which mRNA expres-
sion was 50 % of the initial level) in the HuRsi group.
However, the half-life in the Consi group was signifi-
cantly prolonged especially under the PDGF stimula-
tion, indicating that HuR might enhance the TGF-β1
mRNA stability. Moreover, Bai [27] ever demonstrated
direct interaction between HuR and TGF-β1 3′UTR
by performing RNA-IP in cardiac fibroblasts. Thus,
we considered that HuR mediated TGF-β1 expression
via stablizing TGF-β1 mRNA in ASM cells.
Furthermore, the western blotting and the cultured
medium showed lower expression of Col-I in the HuRsi
group than in the Consi group (Fig 4d) (Table 3). Likewise,
the expression of α-SMA in the HuRi group were reduced
a lot especially in 12 h (Fig 4e). These results facilitated
the hypothesis that HuR might effectively modulate
the expression of Col-I and α-SMA via modulating
the expression of TGF-β1.
Suppression of TGF-β1 ablates HuR and Col-I expression
but exogenous TGF-β1 restored HuR and Col-I expression
in ASM cells
In order to test whether TGF-β1 could affect HuR ex-
pression, ASM cells were transfected with small interfer-
ence RNA to alleviate TGF-β1 expression. We found
that ASM cells in TGFsi group owned lower survival
rate than the Consi group on the PDGF stimulation for
12 h (Fig 5a). As seen from Fig 5b, the relative expres-
sion of TGF-β1 protein in TGFsi group was reduced
23.8 % compared with the Consi group. Upon the affec-
tion of TGF-β1 on HuR and Col-I, the grey value of
bands alleviated respectively (Fig 5c). However, when the
TGF-β1-blockaded ASM cells were treated with 4 ng/ml
TGF-β1 for 12 h, HuR elevated 89 % under the stimula-
tion of extra TGF-β1 and PDGF compared with the con-
trol group, while PDGF treatment alone elevated 40 %
expression of HuR (Fig 5d). Besides, TGF-β1 treatment
could also improve Col-I expression (Fig 5e). These data
further corroborated our hypothesis that a HuR/TGF-β1
feedback existed among ASM cells to regulate airway
remodeling, especially in the expression of Col-I and
α-SMA.
OVA-induced mice owned high amount of inflammatory
cells and collagen type I, III and IV deposition
Eosinophils are critical for the development of airway re-
modeling [28]. We showed that chronic exposure to
OVA induced a robust airway inflammation, character-
ized by the accumulation of inflammatory cells, such as
eosinophils, lymphocytes and netrophils. Elevations in
the total cell numbers, and the percentages of macro-
phages, eosinophils, lymphocytes and neutrophils (7.56
± 1.53 × 106/ml, 28.20 ± 1.95, 35.40 ± 2.02, 26.70 ± 2.38
and 7.08 ± 0.74 %, respectively) were observed in the
BALF of OVA-exposed mice compared with the values
that were observed in PBS controls (3.69 ± 0.98 × 106/ml,
68.88 ± 2.73, 6.25 ± 0.95, 18.12 ± 1.58 and 3.02 ± 0.63 %,
respectively) (Fig 6a-d). Sirius red staining could distin-
guish collagen types. In our study, we interestingly found
large amount of type I and III collagen deposition sur-
rounding the peribronchioles, which directly evidenced
(See figure on previous page.)
Fig. 2 PDGF treatment promoted TGF-β1 along with Col-I and α-SMA expression. a–d HuR, TGF-β1, Col-I and α-SMA mRNA levels were measured
by RT-PCR and protein levels were measured by western blotting in ASM cells under the stimulation of PDGF for various durations (0, 6, 12, 24 h).
GAPDH in RT-PCR and β-actin in western blotting were the internal control. Density ratio of bands in western blotting was calculated and represented
as relative expression level. Each value represents the mean ± SD of three independent experiments. e Immunofluorescence analysis was used to
detect subcellular distribution of HuR and TGF-β1 in ASM cells following the same treatment. *P < 0.05 compared with control; **P < 0.01 compared
with control
Table 2 Relative expression of TGF-β1, Col-I and α-SMA in mRNA and protein levels
Group TGF-β1 Col-I α-SMA
mRNA Protein mRNA Protein mRNA Protein
0 h 1.00 ± 0.00 0.67 ± 0.08 1.00 ± 0.00 0.89 ± 0.10 1.00 ± 0.00 0.88 ± 0.08
6 h 1.27 ± 0.06 0.88 ± 0.10a 1.12 ± 0.14 1.02 ± 0.07 1.35 ± 0.14 1.22 ± 0.17a
12 h 1.60 ± 0.10b 1.13 ± 0.10ab 1.48 ± 0.17b 1.13 ± 0.08b 1.73 ± 0.17b 1.61 ± 0.14ab
24 h 1.87 ± 0.10bc 1.38 ± 0.10abc 1.69 ± 0.10bc 1.33 ± 0.10bc 2.07 ± 0.10bc 1.98 ± 0.15abc
Note:compared with 0 h, aP < 0.05;compared with 6 h, bP < 0.05; compared with 12 h, cP < 0.05
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airway remodeling existed in mice (I: orange; III: green;).
Furthermore, PAS staining revealed that OVA induced
goblet cell hyperplasia in the airway epithelium while
PBS showed little change (Fig 6e). These results clearly
indicate that OVA effectively promotes airway remodel-
ing in mice.
HuR, TGF-β1 and α-SMA were upregulated in chronic
OVA-exposed asthmatic mice airways
To further understand the HuR/TGF-β1 feedback in
vivo, we found that chronic OVA-challenged mice also
highly expressed HuR, TGF-β1 and α-SMA in mRNA
levels and protein levels of lung tissues (Fig 7a&b). As
shown in Fig 7c, the results of immunohistochemistry
showed a significant increase of three proteins in OVA-
induced mice, which was well consistent with the results
of western blotting. Overall, these data illustrated that
OVA-induced airway remodeling is associated with the
high expression of HuR, TGF-β1 and α-SMA.
Discussion
In vitro and in vivo, the present study found that the
effects of HuR and TGF-β1 are inter-dependent, and
the balance among these interactions plays an import-
ant role in mediating airway remodeling. Here, we
uncovered a HuR/TGF-β1 feedback that modulates α-
SMA and Col-I expression in ASM cells or asthmatic
animal mice.
Asthma is a common respiratory disease and the
occurrence of which might be associated with the over-
expression of asthma-associated genes. Human antigen R
(HuR), an ubiquitously expressed RNA-binding protein, is
known to regulate the turnover of mRNA for inflamma-
tory genes or cell cycle proteins by binding to adenylate-
Fig. 3 HuR silencing changed the function of ASM cells. a FACS analysis of the apoptotic and necrotic cells using Annexin V/PI after cultured for
0 h or 12 h in the Consi and HuRsi groups. Annexin V/PI staining with FACScan dot plot analysis were used to divide the treated and control
cells into three groups: living cells (lower left quadrant), necrotic cells (upper right quadrant). b Knockdown efficiency of HuR was analyzed by
RT-PCR and western blot assay. GAPDH in RT-PCR and β-actin in western blotting were the internal control. Density ratio of bands in western
blotting was calculated and represented as relative expression level. *P < 0.05 compared with control; #P < 0.05 control siRNA vs. HuR siRNA
upon the 12 h stimulation of PDGF
Wang et al. Respiratory Research  (2016) 17:117 Page 8 of 15
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uridylate-rich elements and related motifs presented in
the 3′untranslated region (UTR) of mRNAs. Our previous
studies demonstrated that HuR could enhance cyclinD1
mRNA stability by recognizing the 3′UTR, which con-
trolled the proliferation of ASM cells. Airway remodeling,
a key feature of asthma, is characterized by matrix depos-
ition and enhanced smooth muscle mass in the airways.
For years, multiple intracellular signal pathways have been
shown to be involved. p38 mitogen-activated protein kin-
ase (MAPK) signaling has been shown to be a center to
the TGF-β1-induced collagen and fibronectin expression
in systemic sclerosis (SSc) fibroblasts [29]. As TGF-β1 in-
duces fibroblasts to synthesize and ECM contract, this
cytokine has long been believed to be a central mediator
of the fibrotic response [30]. In light of the analysis above,
whether HuR is involved in matrix deposition and how it
mediates this event in cultured ASM cells is the focus of
our study, and we set to explore the interaction between
HuR and TGF-β1 with the goal of defining a new role for
HuR in asthma.
Firstly, we found that PDGF stimulation significantly
elevated the expression of TGF-β1, α-SMA and Col-I both
in the mRNA and protein levels at a time-dependent
manner. Furthermore, the result of immunofluorescence
of HuR and TGF-β1 were well consistent with western
blotting and PCR analysis. These data proved that PDGF
stimulation significantly elevated the expression of TGF-
β1, α-SMA and Col-I. Secondly, RNA-interference de-
creased the expression of HuR to a very low level.
Suppression of HuR resulted in higher proportion of
apoptosis in the HuRsi group than in the Consi group
and the contents of TGF-β1, Col-I and α-SMA either
in intracelluar or in the cultured medium were re-
duced in HuRsi group. Furthermore, we detected that
the half-life of TGF-β1 mRNA was also much shorter
compared with the control, which was similar to
some reported studies demonstrating that HuR could
regulate target mRNA expression by prolonging or short-
ening the mRNA half-life [31–33]. Thirdly, to further ex-
plore the association between HuR and TGF-β1, TGF-β1
was inhibited by specific small interference RNA. We
interestingly found that the knockdown of TGF-β1 also al-
leviated HuR and Col-I expression in western blotting and
extra addition of TGF-β1 could partially recover HuR and
Col-I expression in ASM cells, which gives us confidence
that a HuR/TGF-β1 may exist to modulate airway remod-
eling. At last, OVA-driven mice showed widely infiltration
of inflammatory cells around the bronchiole compared
with PBS-induced mice. Sirius red staining distinguished
collagen type I and III deposition surrounding the
bronchiole especially in the OVA-induced mice. Immu-
nohistochemistry plus western blotting and RT-PCR
showed higher levels of HuR, TGF-β1 and α-SMA in
the OVA -induced mice. Thus we hypothesized that a
HuR/TGF-β1 feedback is involved in airway remodeling
and targeting them may have considerable potential for
the control of asthma.
B Wightman [34] ever demonstrated that stretch aug-
mented TGF-β1 expression through the enhanced acti-
vation of the promoter,which indicating that targeting
the posttranscriptional regulatory modules in the TGF-
β1 signaling pathway is a promising approach to control
airway remodeling by ASM cells. Danna Bai [27] used
RNA-IP to verify that HuR could recognize the 3′UTR
of TGF-β1 in cardiac fibroblasts. Their study established
that a TGF-β1/HuR feedback circuit regulated the fibro-
genic response in fibroblasts. This mechanism should
also exist in other organisms on the basis that both HuR
(See figure on previous page.)
Fig. 4 HuR silencing attenuated TGF-β1 along with Col-I and α-SMA expression and decreased the mRNA stability of TGF-β1. a Silenced HuR
downregulated endogenous TGF-β1 protein expression at a time-dependent manner. Density of each band was quantified using Image software
and the ratio of bands was calculated and represented as relative expression level. b The concentration of TGF-β1 in the cultured serum
was detected by ELISA kits. Data was analysed by Curve Expert and showed by mean ± SD. c Remaining TGF-β1 mRNA were detected in
siHuR or Consi group with stimulation of actinomycinD for 0, 4, 8,12 h. RNA expression was 50 % of the initial level [t1/2 = Ln(0.5)/slope])
representing the half-life. Graphpad prism5.0 was used to analyse data and data was shown with mean ± SD. d Western blotting showed
significant decrease of Col-I after the knockdown of HuR. The outcomes of the concentration of Col-I in the cultured serum was in consist with western
blotting. e Western blotting demonstrated alleviatin of α-SMA expression after silencing HuR. *P < 0.05 compared with control; #P < 0.05 control siRNA
vs. HuR siRNA upon the stimulation of PDGF for 12 h or 24 h
Table 3 The concentration of TGF-β1 and Col-I in the cultured serum (pg/ml)
Group TGF-β1 Col-I
Consi HuRsi Consi HuRsi
0 h 773.33 ± 16.32 277.33 ± 9.93 106.60 ± 5.19 70.95 ± 4.90
6 h 877.97 ± 16.03 407.77 ± 7.14a 332.11 ± 10.91 238.5 ± 9.28
12 h 3060.34 ± 82.53 828.05 ± 11.67ab 518.23 ± 14.62 376.50 ± 12.44b
24 h 4338.13 ± 72.48 3958.06 ± 80.98abc 988.56 ± 20.11 628.51 ± 18.91bc
Note:compared with 0 h, aP < 0.05;compared with 6 h, bP < 0.05; compared with 12 h, cP < 0.05
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and the ARE in the TGF-β1 3′UTR are conserved
among various species. Increased TGF-β1 would induce
a cascade of the fibrogenic response in both the canon-
ical Smad-dependent signaling pathway and non-Smad
pathways by inducing the expression of collagen, fibro-
nectin and other ECM molecules [4]. However, we have
only tested a limited indicator of remodeling, Col-I and
α-SMA. Numerous publications have confirmed that
proliferative cytokines [35] and proinflammatory factors
[36] are also involved in airway remodeling. It is there-
fore an important challenge to test other potential
targets that are involved in controlling the process of
airway remodeling.
Previous studies have shown that the actions of TGF-β1
on fibroblast proliferation are complex. The proliferation
of mink lung fibroblasts is stimulated by low concentra-
tions of TGF-β1 (5–10 ng) but inhibited by higher con-
centrations [37]. Treatment of ASM cells with TGF-β1
(4 ng/ml) resulted in a dramatic increase in HuR and
Col-I expression compared with the untreated controls
or PDGF alone. Our present study established a HuR/
TGF-β1 feedback that might regulate the Col-I expression
Fig. 5 Suppression of TGF-β1 ablated HuR and Col-I expression but exogenous TGF-β1 restored HuR and Col-I expression. a Knockdown of TGF-β1
decreased ASM cells viability by CCK8 assay. b Small interfere RNA decreased TGF-β1 expression compared with control siRNA. (c) After
silencing TGF-β1, HuR and Col-I were also alleviated even though under the stimulation of PDGF. d–e Exogenous TGF-β1 treatment increased
endogenous HuR and Col-I expression.β-actin in western blotting were the internal control. Density ratio of bands in western blotting was calculated
and represented as relative expression level. *P < 0.05 compared with control; #P < 0.05 control siRNA vs. TGF-β1 siRNA
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in ASM cells, and suggested that targeting this pathway
has considerable potential for controlling the deposition
of Col-I in ASM cells. However, the mechanism by which
TGF-β1 regulates Col-I and α-SMA expression is still un-
clear. In mesangial cells, TGF-β1 induction of the type I
collagen promoter required the RAS/MEK/ERK MAPK
cascade, and in dermal fibroblasts, this response required
p38 [38]. Induction of fibronectin by TGF-β1 in fibro-
blasts was Smad-independent but required the JNK
MAPK cascade and c-jun [39]. Our next study will further
explore the novel pathway between TGF-β1, α-SMA and
Col-I in ASM cells.
More than 300 million individuals worldwide are
suffered from asthma, and by 2025 the prevalence is
predicted to increase by 100 million [40]. At present,
inhaled corticosteroids are the standard therapy for
persistent asthma; however, the antioxidant effects of
corticosteroids are unsatisfied. Furthermore, this treat-
ment is hindered when steroid dependence or steroid re-
sistance occurs [41]. Therefore, the development of novel
and efficient therapeutic strategies is of great significance
in the control of asthma. We have described a HuR/TGF-
β1 feedback that mediates airway remodeling in vivo and
in vitro. Although experimental studies have adequately
Fig. 6 OVA-induced mice owned high amount of inflammatory cells and type I and III collagen deposition. Inflammatory cell recruitment in BALF
of OVA-induced asthma: a Macrophages; b Eosinophils; c Lymphocytes; d Neutrophils. e Representative HE staining of lung tissues showed the
large infiltration of inflammatory cells in OVA-induced mice; Representative PAS staining showed widely globet cell hyperplasia in OVA-induced
mice compared with PBS-induced mice. Sirus red staining showed large amount of type I, III collagen deposition in OVA-induced mice. (I: red or
orange; III: green; IV: light yellow) *P < 0.05 OVA vs. PBS; ***P < 0.001 OVA vs. PBS
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demonstrated that blocking these signaling pathways, es-
pecially TGF-β1, could effectively decrease airway remod-
eling, no such chemical inhibitors are clinically available
at the present time. Interventions that target TGF-β1 are
limited to acute situations, such as immediately after sur-
gery, that would require application of the anti-fibrotic for
a limited period. Such strategies might not be appropriate
for the treatment of chronic fibrotic diseases that develop
over many years, on the basis of the long period of dosing
necessary for such diseases.
The post-transcriptional regulation of gene expression
includes mRNA transportation, procession, turnover, and
mRNA translation.Targeting this pathway has consider-
able potential to control the deterioration of lung function
due to asthma. HuR, as an upstream modulator of TGF-
β1, serves to provide a novel insight for searching the
Fig. 7 HuR, TGF-β1 and α-SMA were upregulated in chronic OVA-exposed asthmatic mice airways. a–b Representative protein bands of TGF-β1,
HuR and α-SMA were determined by western blotting. mRNA levels were measured by RT-PCR in lung tissues of mice. β-actin in western blotting
and GAPDH in RT-PCR were the internal control. *P < 0.05 OVA vs. PBS; c Representative HuR, TGF-β1 and α-SMA expression were determined by
immunohistochemistry; the positive area was calculated as positive area/total bronchiole area in similar size bronchia from each group
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precise target of asthmatic airway remodeling. Thus, the
future research will focus on silencing HuR in mice to ex-
plore a new road being clinically appropriate for control-
ling asthma.
Conclusion
A HuR/TGF-β1 feedback circuit was established to regu-
late airway remodeling in vivo and in vitro and targeting
this feedback has considerable potential for the control
of asthma.
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